Short Steroid Courses Raise Risk of Serious Events in Diabetes
In a study of over 36,000 patients with type 2 diabetes, short oral corticosteroid bursts were linked to increased 30-day risks of pneumonia, heart failure, and gastrointestinal bleeding. Elevated risks for sepsis and fracture were also observed. The authors advise judicious prescribing of oral corticosteroids in this high-risk population.
The study drew on Taiwan's National Health Insurance Research Database, covering 2008 through 2022, and included more than 36,000 adults with type 2 diabetes who received short oral corticosteroid bursts averaging 4.5 days. Patients were roughly 62 years old on average, with slightly more women than men. Family practice and dermatology were the most common prescribing specialties, followed by internal medicine and otolaryngology.
The researchers used a self-controlled case series design, comparing each patient's risk during the 6-30 days after starting a steroid burst against baseline periods. Sensitivity analyses that adjusted for burst definitions up to 30 days, excluded death events, and used alternative washout windows produced consistent results. A negative control outcome, syncope, showed no significant association, lending credibility to the findings.
This study could prompt clinicians to weigh steroid bursts more carefully in diabetic patients, potentially shifting prescribing habits toward alternative treatments for self-limited conditions. Patients with type 2 diabetes may benefit from closer monitoring or earlier intervention when steroids are unavoidable. The findings may also influence guideline updates, though the observational design means causality remains uncertain. Broader awareness of these risks could reduce preventable hospitalizations for pneumonia, heart failure, and bleeding in this vulnerable population.